Cargando…

Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy

Background: The global increase of obesity parallels the obesity-related glomerulopathy (ORG) epidemic. Dipeptidyl peptidase 4 inhibitors and glucagon-like peptide-1 receptor agonists were well recognized to attenuate renal injury independent of glucose control in diabetic nephropathy. There are lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jiao, Yuan, Geheng, Cheng, Fangxiao, Zhang, Junqing, Guo, Xiaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576269/ https://www.ncbi.nlm.nih.gov/pubmed/28737448 http://dx.doi.org/10.1089/met.2017.0057

Ejemplares similares

Aberrant expression of miR-214 is associated with obesity-induced insulin resistance as a biomarker and therapeutic
por: Cheng, Fangxiao, et al.
Publicado: (2020)

Dysregulation of DPP4 Is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes Under Insulin Resistance Status and Liraglutide Intervention
por: Cheng, Fangxiao, et al.
Publicado: (2019)

Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy
por: Takasaki, Satoshi, et al.
Publicado: (2015)

Glomerulopathy Associated With Moderate Obesity
por: Okabayashi, Yusuke, et al.
Publicado: (2016)

Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression
por: Shao, Yimin, et al.
Publicado: (2015)

Histiocytic glomerulopathy associated with macrophage activation syndrome
por: Eirin, Alfonso, et al.
Publicado: (2015)

Editorial: Incretin agonists in the treatment of obesity
por: Sun, Xiaodong, et al.
Publicado: (2023)

Inflammation and Oxidative Stress in Obesity-Related Glomerulopathy
por: Tang, Jinhua, et al.
Publicado: (2012)

Obesity-Related Glomerulopathy and Single-Nephron GFR
por: Denic, Aleksandar, et al.
Publicado: (2020)

Glomerulopathy
por: Boaz, Noel T, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System
por: Lu, Difei, et al.
Publicado: (2022)

Single-Nephron GFR in Patients With Obesity-Related Glomerulopathy
por: Okabayashi, Yusuke, et al.
Publicado: (2020)

Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target
por: Wei, Lifang, et al.
Publicado: (2021)

Obesity‐related glomerulopathy: Current approaches and future perspectives
por: Martínez‐Montoro, José Ignacio, et al.
Publicado: (2022)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Fibronectin glomerulopathy
por: Ishimoto, Ikue, et al.
Publicado: (2013)

Collagenofibrotic glomerulopathy
por: Kurien, Anila Abraham, et al.
Publicado: (2015)

Collagenofibrotic Glomerulopathy
por: Reddy, M. H. K., et al.
Publicado: (2017)

Collagenofibrotic Glomerulopathy
por: Miyake, Masato, et al.
Publicado: (2020)

Viral Glomerulopathy
por: Deoliveira, Margaret, et al.
Publicado: (2023)

Obesity-associated metabolic syndrome spontaneously induces infiltration of pro-inflammatory macrophage in synovium and promotes osteoarthritis
por: Sun, Antonia RuJia, et al.
Publicado: (2017)

Momordica charantia (Bitter Melon) Reduces Obesity-Associated Macrophage and Mast Cell Infiltration as well as Inflammatory Cytokine Expression in Adipose Tissues
por: Bao, Bin, et al.
Publicado: (2013)

Obesity-Related Glomerulopathy: Hyperfiltration May Contribute to Early Proteinuria
por: Edwards, Aurélie, et al.
Publicado: (2021)

Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care
por: Mangat, Guneive, et al.
Publicado: (2022)

Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy
por: Ye, Muyao, et al.
Publicado: (2023)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Infiltration of mast cells in pachydermia of pachydermoperiostosis
por: Tanese, Keiji, et al.
Publicado: (2017)

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
por: Michałowska, Joanna, et al.
Publicado: (2021)

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
por: Tan, Qiming, et al.
Publicado: (2022)

C3 glomerulopathy
por: Cook, H. Terence
Publicado: (2017)

Autoimmune Thyroiditis and Glomerulopathies
por: Santoro, Domenico, et al.
Publicado: (2017)

Infections and Collapsing Glomerulopathy
por: Moktefi, Anissa, et al.
Publicado: (2020)

Use of rituximab in glomerulopathies
por: Dias, Cristiane Bitencourt, et al.
Publicado: (2022)

Systemic NK cell ablation attenuates intra-abdominal adipose tissue macrophage infiltration in murine obesity
por: O’Rourke, Robert W., et al.
Publicado: (2014)

Response to Obesity-Related Glomerulopathy: Hyperfiltration may Contribute to early Proteinuria
por: Okabayashi, Yusuke, et al.
Publicado: (2021)

Pharmacological antagonism of the incretin system protects against diet-induced obesity
por: Svendsen, Berit, et al.
Publicado: (2019)

GIP: An Inconsequential Incretin or Not?
por: Pratley, Richard E.
Publicado: (2010)

Pleiotropic effects of incretins
por: Gupta, Vishal
Publicado: (2012)

Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_924lqdc1ahdiuclpklfjpkbudo